Zoekresultaten - 200 results
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
Publication Type: Peer reviewed scientific article Authors: Fröberg, Maria; Östensson, Ellinor; Belkić, Karen; Anja Oštrbenk; Poljak, Mario; Mints, Miriam; M. Arbyn; Andersson, Sonia Source: Cancer, ...
The EMPCAN study: protocol of a population-based cohort study on the evolution of the socio-economic position of workers with cancer
colorectal, breast, head & neck, prostate, testis, lung and corpus uteri cancer. The end of (administrative) follow-up was 31st December 2012. We include demographic, health-related and work-related factors ...
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia
Adam; Butler, Katherine; Darlington-Brown, Jessica; Hui, Harriet; Brotherton, Julia; Skinner, Rachel; Brand, A; Roeske, Lara; Heley, Stella; Carter, Jonathan; Bateson, Deborah; Frazer, Ian; Garland, ...
Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.
whole female population were obtained from the two cancer registries. During 2008-2011, 565 153 smears were performed in 498 913 women aged 25-64 years, representing an average of 1.13 smears/woman and ...
Patient Reported Outcome Measures (PROM's) bij diabetesvoet
Publication Type: Non-peer reviewed scientific publication Authors: Wahid Rezaie; Flora Mbela Lusendi; Kris Doggen; Frank Nobels Source: Vlaams tijdschrift voor diabetologie, Diabetes Liga, Issue 2, ...
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
0.97 to 1.02). However, hrHPV assays based on signal amplification were less sensitive on self samples (pooled ratio 0.85, 95% confidence interval 0.80 to 0.89). The specificity to exclude CIN2 + was 2% ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
specificity of 1.00 (95% CI, 0.99 to 1.01) (value of >0.05 in all cases). Regardless of the clinical outcome (CIN2 + or CIN3 +), age restriction (women ≥30 years old), or comparator test used, Anyplex ...
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Publication Type: Peer reviewed scientific article Authors: Akbari, Ajmal; Vanden Broeck, Davy; Benoy, Ina; Padalko, Elizaveta; Bogers, Johannes; M. Arbyn Source: Virol J, Volume 15, Issue 1 (2018) ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; E Peeters; I Benoy; D Vanden Broeck; J Bogers; P De Sutter; G Donders; W Tjalma; S Weyers; Cuschieri, K; Poljak, M; J Bonde; ...
Moving towards a comprehensive diabetes data registry
Publication Type: Popular-science publication (vulgarising publication) Authors: Kris Doggen Source: Government Gazette, International Centre for Parliamentary Studies, Volume 3, Issue 3, Number 51, ...